Khi sức mạnh tính toán của AI cũng bắt đầu được "chia sẻ", ai sẽ trở thành người dẫn đầu trong cuộc cạnh tranh mới này?

Cambrian Biopharma

company

About

Cambrian is a distributed development company building therapeutics to lengthen health span.

  • 11 - 50

Details

Last Funding Type
Series A
Industries
Biopharma,Biotechnology,Life Science
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.

As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$160M
Cambrian Biopharma has raised a total of $160M in funding over 2 rounds. Their latest funding was raised on Oct 26, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 26, 2021 Series C $100M 2 Detail
Feb 9, 2021 Series B $60M 1 Detail
Nov 1, 2019 Series A 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Cambrian Biopharma has made 1 investments. Their most recent investment was on Apr 13, 2021, when Arcellx raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 13, 2021 Arcellx
Series C Biopharma

Investors

Number of Lead Investors
Number of Investors
3
Cambrian Biopharma is funded by 3 investors. Korify Capital and Kliwla Family Office AG are the most recent investors.
Investor Name Lead Investor Funding Round
Korify Capital Series C
Kliwla Family Office AG Series C
NJF Capital Series A